Genome Research Limited for the Wellcome Sanger Institute

Date of Award

08.10.2022

Program

Therapeutics

Amount

$1,539,606.00

Term of Grant

36 months

Project Title

scIBD-RESPONSE: Massive-scale single-cell RNA-sequencing to identify transcriptomic predictors of response to biologic therapies in Crohn's disease

Project Description

This grant aims to provide an understanding of CD genetics and gene expression at unprecedented scale and can pave the way to better predict patient response to therapeutics and provide new insight into disease mechanisms.